Edition:
United Kingdom

AcelRx Pharmaceuticals Inc (ACRX.OQ)

ACRX.OQ on NASDAQ Stock Exchange Global Market

3.36USD
7 Dec 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$3.36
Open
$3.25
Day's High
$3.43
Day's Low
$3.15
Volume
313,258
Avg. Vol
539,224
52-wk High
$5.05
52-wk Low
$1.65

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.38 -0.208
Jun '18 0.82 -0.203
Mar '18 0.34 -0.228
FY 2017 Dec '17 0.74 0.480
Sep '17 1.49 -0.281
Jun '17 2.66 -0.288
Mar '17 3.11 -0.343
FY 2016 Dec '16 6.43 -0.214
Sep '16 3.37 -0.252
Jun '16 4.53 -0.245
Mar '16 3.03 -0.242
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 6 1.70 8.50 0.20 2.30
Quarter Ending Mar-19 4 0.53 1.10 0.20 --
Year Ending Dec-18 7 3.05 10.00 1.74 14.27
Year Ending Dec-19 8 8.43 13.30 4.85 20.54
Earnings (per share)
Quarter Ending Dec-18 6 -0.21 -0.14 -0.24 -0.19
Quarter Ending Mar-19 5 -0.24 -0.20 -0.27 --
Year Ending Dec-18 6 -0.86 -0.77 -0.92 -1.01
Year Ending Dec-19 8 -0.97 -0.71 -1.24 -0.85
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 92.25 33.63
P/E High - Last 5 Yrs. -- 323.36 45.43
P/E Low - Last 5 Yrs. -- 90.29 24.43
Beta 3.03 0.91 0.90
Price to Sales (TTM) 14.87 116.41 5.77
Price to Book (MRQ) -- 15.60 5.12
Price to Tangible Book (MRQ) -- 14.89 6.54
Price to Cash Flow (TTM) -- 72.75 23.57
% Owned Institutions 39.70 12.59 1.83

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.49
Dividend Yield - 5 Year Avg -- 0.31 1.50
Dividend 5 Year Growth Rate -- 2.65 5.08
Payout Ratio(TTM) -- 23.68 43.75

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -41.32 358.89 7.43
Sales (TTM) vs TTM 1 Yr. Ago -37.00 90.38 5.80
Sales - 5 Yr. Growth Rate 74.52 31.32 10.19
EPS (MRQ) vs Qtr. 1 Yr. Ago -17.56 36.71 21.03
EPS (TTM) vs TTM 1 Yr. Ago -79.25 -- --
EPS - 5 Yr. Growth Rate -- 39.68 10.79
Capital Spending - 5 Yr. Growth Rate 13.00 39.59 15.12

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 4.81 1.98 2.28
Current Ratio (MRQ) 4.92 5.42 3.11
LT Debt to Equity (MRQ) -- 33.58 11.47
Total Debt to Equity (MRQ) -- 35.41 15.63
Interest Coverage (TTM) -1.82 -152.89 31.38

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 13.88 41.87 54.21
Gross Margin - 5 Yr. Avg. -- 49.14 51.98
EBITD Margin (TTM) -225.81 -- --
EBITD - 5 Yr. Avg -161.51 -506.71 11.83
Operating Margin (TTM) -238.47 -728.63 4.90
Operating Margin - 5 Yr. Avg. -170.81 -526.19 7.44
Pre-Tax Margin (TTM) -319.40 -694.90 5.91
Pre-Tax Margin - 5 Yr. Avg. -212.89 -531.06 7.89
Net Profit Margin (TTM) -319.19 -696.67 2.16
Net Profit Margin - 5 Yr. Avg. -213.88 -534.50 4.12
Effective Tax Rate (TTM) -- 25.12 23.36
Effective Tax Rate - 5 Yr. Avg. -- 20.63 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 399,205 25,687,363 898,926,015
Net Income/Employee (TTM) -1,274,205 2,194,067 106,550,787
Receivable Turnover (TTM) 4.98 18.46 5.94
Inventory Turnover (TTM) 9.22 2.61 3.62
Asset Turnover (TTM) 0.16 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -51.83 -1.11 11.50
Return on Assets - 5 Yr. Avg. -34.34 2.88 12.67
Return on Investment (TTM) -63.23 0.28 15.02
Return on Investment - 5 Yr. Avg. -39.19 1.84 16.45
Return on Equity (TTM) -- 0.94 16.60
Return on Equity - 5 Yr. Avg. -81.78 2.30 17.56
  1 Year 3 Year 5 Year
Sales % -9.89 -16.21 74.52
EPS (TTM) % -72.93 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AcelRx Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 54.55 49.22 95 57
13 Week 142.86 131.03 98 62
26 Week 85.45 71.36 90 81
52 Week 35.64 14.96 71 47
YTD 96.15 72.26 85 60
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 9.75%
# of Holders: 69
Total Shares Held: 7,262,213
3 Mo. Net Change: 1,124,481
# New Positions: 15
# Closed Positions: 14
# Increased Positions: 41
# Reduced Positions: 27
# Net Buyers: 14
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.